{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:15:08Z","timestamp":1648937708626},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.arteri.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T10:15:28Z","timestamp":1418379328000},"page":"74-79","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gu\u00edas 2013 ACC\/AHA riesgo cardiovascular. De evidencias incompletas y fallido intento de simplificaci\u00f3n"],"prefix":"10.1016","volume":"27","author":[{"given":"Pablo","family":"Corral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2014.07.001_bib0005","first-page":"S46","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"24","author":"Stone","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2014.07.001_bib0010","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2014.07.001_bib0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jacc.2013.01.079","article-title":"Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications","volume":"62","author":"Martin","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2014.07.001_bib0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archinte.1988.00380010040006","article-title":"Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","volume":"148","year":"1988","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.arteri.2014.07.001_bib0025","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.1993.03500230097036","article-title":"Summary of the Second Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel II)","volume":"269","year":"1993","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2014.07.001_bib0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.arteri.2014.07.001_bib0035","doi-asserted-by":"crossref","first-page":"e961","DOI":"10.1016\/j.amjmed.2009.03.030","article-title":"Effect of fibrates on lipid profiles and cardiovascular outcomes: A systematic review","volume":"122","author":"Abourbih","year":"2009","journal-title":"Am J Med."},{"key":"10.1016\/j.arteri.2014.07.001_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results I. Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2014.07.001_bib0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2014.07.001_bib0050","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC, guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: en- dorsed by the National Heart, Lung and Blood Institute","volume":"113","author":"Smith Jr","year":"2006","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2014.07.001_bib0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.atherosclerosis.2006.08.039","article-title":"The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population","volume":"193","author":"Hooper","year":"2007","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2014.07.001_bib0060","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)62388-0","article-title":"Statins: New American guidelines for prevention of cardiovascular disease","volume":"382","author":"Ridker","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2014.07.001_bib0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/CS20070265","article-title":"Non-HDL cholesterol and apoB in dyslipidaemia","volume":"114","author":"Sniderman","year":"2008","journal-title":"Clin Sci (London)."},{"key":"10.1016\/j.arteri.2014.07.001_bib0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.mayocp.2013.07.012","article-title":"The necessity for clinical reasoning in the era of evidence-based medicine","volume":"88","author":"Sniderman","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.arteri.2014.07.001_bib0075","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.clinthera.2007.08.022","article-title":"Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225","volume":"29","author":"Nichols","year":"2007","journal-title":"Clin Ther."},{"key":"10.1016\/j.arteri.2014.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2009.06.041","volume":"54","author":"Cleland","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2014.07.001_bib0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2014.07.001_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2011.06.028","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2014.07.001_bib0095","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jacc.2013.11.054","article-title":"Should we forget about low-density lipoprotein cholesterol?","volume":"63","author":"Civeira","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2014.07.001_bib0100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cjca.2012.11.032","article-title":"2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.arteri.2014.07.001_bib0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jacl.2013.10.001","article-title":"An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia","volume":"7","author":"Grundy","year":"2013","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2014.07.001_bib0110","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","year":"2014","journal-title":"Heart."},{"key":"10.1016\/j.arteri.2014.07.001_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary","volume":"8","author":"Jacobson","year":"2014","journal-title":"J Clin Lipidol."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916814001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916814001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T02:20:26Z","timestamp":1538014826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916814001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0214916814001016"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2014.07.001","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gu\u00edas 2013 ACC\/AHA riesgo cardiovascular. De evidencias incompletas y fallido intento de simplificaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}